Prognostic Significance of the Severity of Immune-Related Adverse Events in Advanced Cancer Patients Treated with PD-1/PD-L1 Inhibitors: A Real-World Data Analysis.
| Publicado en: | Targeted Oncology p. 1 |
|---|---|
| Autores principales: | , , , , , , , |
| Formato: | Journal Article |
| Publicado: |
Springer Nature
Dec2022
|
| Acceso en línea: | Ver este registro en EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=160781356&site=ehost-live header: @attributes: shortDbName: ccm uiTerm: 160781356 longDbName: CINAHL Complete uiTag: AN controlInfo: bkinfo: dissinfo: jinfo: jid: 17762596 47DQ jtl: Targeted Oncology issn: 17762596 maglogo: N pubinfo: dt: Dec2022 pid: 237 pub: Springer Nature place: New York, New York artinfo: ui: 160781356 10.1007/s11523-022-00936-4 160781356 ppf: 1 formats: fmt: @attributes: type: P tig: atl: Prognostic Significance of the Severity of Immune-Related Adverse Events in Advanced Cancer Patients Treated with PD-1/PD-L1 Inhibitors: A Real-World Data Analysis. aug: au: Song, Su Jeong Song, Yun-Kyoung Jang, Mihwa Shin, Eunjeong Suh, Sung Yun Cho, Yoon Sook Lee, Ju-Yeun Oh, Jung Mi affil: Department of Pharmacy, Seoul National University Hospital sug: pubtype: Academic Journal doctype: Journal Article ougenre: Article ab: language: English refInfo: holdings: @attributes: islocal: N |
|---|